Cardarine (GW-501516) is drug that binds towards the PPAR receptor. It was initially produced by Glaxo Smith Kline and Ligand Pharmaceuticals in 1992. It was found that Cardarine, when binding for the PPAR receptor, recruits what's named the coactivator PGC-1a enzyme, which then increases the expression of genes involved in the exs properly as an enhanced protection from type-2 diabetes. In one mo